tirzepatide approval FDA confirms shortage is still over, gives compounders a grace period Eli Lilly's tirzepatide gained FDA

It mimics the GLP-1 hormone in your intestine, which boosts insulin release, reduces blood sugar, suppresses appetite, and makes you feel fuller faster

Reconstituting multiple vials at once Some researchers reconstitute two or three vials at once to save time

These additions are often positioned as enhancements to energy metabolism or weight loss support, and may serve as a rationale for continued compounding despite the FDAs resolution of supply shortages

Tirzepatide is now widely available as a prescription medicine made by Eli Lilly under the brands names Mounjaro (for type 2 diabetes) and Zepbound (for weight loss and sleep apnea)